Krystal Biotech Inc Forecast and Target Price

$164.83

Krystal Biotech Inc (KRYS) Share Price Forecast

Currently 17 wall-street analysts regularly analyze the financials of Krystal Biotech Inc on a frequent basis to provide recommendations along with target share price. 17 analysts offering 12-month price forecasts for Krystal Biotech Inc (KRYS) have a share price target of $207.78. This median of share price forecast represents a 26.06% upside from the latest price of $164.83 as on 22.12.24.

Krystal Biotech Inc (KRYS) Price vs Consensus Price Target

Price

Target Price

As per the chart shown above, analysts believe that the Krystal Biotech Inc (KRYS) share price will touch around $207.78 in next 12-months.

Krystal Biotech Inc (KRYS) Share Price Forecast v/s Share Price Today

Below is a chart showing the percentage difference between Krystal Biotech Inc's share price and its median forecast price. As on 22.12.24, the difference is -15.11%

Krystal Biotech Inc (KRYS): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms

Krystal Biotech Inc (KRYS) Share Price : Analyst Recommendation

Based on 17 analysts tracking and researching Krystal Biotech Inc (KRYS) share have buy recommendation on an average.

	3M Ago	1M Ago	Current
Buy	9	9	9
Outperform	7	7	7
Hold	1	1	1
Underperform	0	0	0
Sell	0	0	0

Krystal Biotech Inc (KRYS) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average

Price

200 Day Moving Average v/s Current Share Price

Moving Average

Price

Become a Global Investor

Start Investing in brands you love

₹0 US Stocks a/c Opening Fee
₹0 Maintenance Charges
₹0 US Stocks Withdrawals*

Invest Now

*Investment in securities market are subject to market risk, read all the related documents carefully before investing. Logos above are the property of their respective trademark owners and by displaying it INDmoney has no right, title or interest over it.

The connector service for US Stocks account is provided by Finzoomers Services Private Limited.

Please be informed that US Stocks are not Indian Exchange traded funds and Finzoomers Services Private Limited merely acts in the capacity of a facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to exchange investor redressal forum or arbitration mechanism in India. The securities quoted are for examples and not to be considered as an advice or recommendation.